Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare DiseasesMargherita Brindisi, Giuseppe Campiani, A. Prasanth Saraswati et al.|Journal of Medicinal Chemistry|2019Cited by 115
Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent InhibitorsGiuseppe Campiani, Antje Prasse, Caterina Cavella et al.|Journal of Medicinal Chemistry|2021Cited by 55
Telomerase-based Cancer Therapeutics: A Review on their Clinical TrialsNicola Relitti, Giuseppe Campiani, A. Prasanth Saraswati et al.|Current Topics in Medicinal Chemistry|2020Cited by 54
Development of Potent Inhibitors of the <i>Mycobacterium tuberculosis</i> Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside MacrophagesMarco Paolino, Simone Brogi, Giovanni Delogu et al.|ChemMedChem|2018Cited by 48
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological EvaluationA. Prasanth Saraswati, Giuseppe Campiani, Nicola Relitti et al.|ACS Medicinal Chemistry Letters|2020Cited by 44